An Iowa woman has sued Organon USA, alleging that their vaginal contraceptive NuvaRing caused her to have a pulmonary embolism. The woman, Sherri Howell of Cedar Rapids, Iowa, first began using NuvaRing in early 2011. On March 30, 2011, at the age of 26, she had shortness of breath and chest pain and was admitted to a hospital where a chest CT revealed she was suffering from a pulmonary embolism. It’s alleged in the suit that Organon knew or should have known that use of its products carries a risk of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, as well as death. The suit alleges further that despite this knowledge, Organon failed to warn consumers of these serious risks before Howell began using NuvaRing.
In addition to pain and suffering, the suit also seeks to recover for economic and non-economic losses, including past and future hospital expenses, as well as punitive damages for the alleged willful or wanton disregard for the rights and safety of the Plaintiff. Organon USA, Inc. is a Roseland, N.J.-based sales unit of the health care group of Akzo Nobel NV and Organon International, Inc., both of which are also listed as Defendants in the suit. If you need more information on this litigation contact Melissa Prickett, a lawyer in our Mass Torts Section, at 800-898-2034 or by email at Melissa.Prickett@beasleyallen.com.
Source: Lawyers USA Online
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.